Zobrazeno 1 - 10
of 27
pro vyhledávání: '"G. De Brabanter"'
Autor:
Philippe Carron, Pieter Hindryckx, H. Cypers, L. Van Praet, I. Vanneuville, J. De Kock, M. De Vos, G. De Brabanter, Kristof Thevissen, G. Varkas, Frank Czul-Gurdian, J. Arts, Barbara Claerhout, F. Van den Bosch, Maria T. Abreu, Dirk Elewaut, P. Schoenaers
Publikováno v:
Annals of the Rheumatic Diseases. 76:878-881
BackgroundIn inflammatory bowel disease (IBD), a new biological therapy has recently been approved. Vedolizumab is a humanised IgG1 monoclonal antibody to α4β7 integrin that modulates gut lymphocyte trafficking. Although an exclusively local effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::439bdf566c601ec0977c4dab2beedb1d
https://doi.org/10.1136/annrheumdis-2016-210233
https://doi.org/10.1136/annrheumdis-2016-210233
Autor:
Rik Joos, G. De Brabanter, K. Vandevyvere, J. Remans, Sabrina Meyfroidt, V. Taelman, René Westhovens, Patrick Verschueren, J. Lenaerts, B. Vander Cruyssen, Piet Geusens, Isabelle Ravelingien, F. Raeman, E. Van Essche, Johan Vanhoof, E. Geens, A. Sileghem, Johan Joly, K. Van der Elst, A. Durnez, Diederik De Cock, L. Corluy, C. Langenaken
Publikováno v:
Annals of the Rheumatic Diseases, 74(1), 27-34. BMJ Publishing Group
ObjectivesTo compare the efficacy and safety of intensive combination strategies with glucocorticoids (GCs) in the first 16 weeks (W) of early rheumatoid arthritis (eRA) treatment, focusing on high-risk patients, in the Care in early RA trial.Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fef1c8e8dd898a41876e8fcda148f1
https://doi.org/10.1136/annrheumdis-2014-205489
https://doi.org/10.1136/annrheumdis-2014-205489
Autor:
J. Qu, G. De Brabanter, P. Geusens, M. Van Den Berghe, Rik Joos, F. Van den Bosch, H. Leroi, I Peene, V. Taelman, A. Nzeusseu Toukap, S. Dall'Armellina, Rik Lories, Serge Steinfeld, J. Lenaerts, M. Maertens, F. Van Bruwaene, Michel Malaise, K. de Vlam
Publikováno v:
Annals of the Rheumatic Diseases. 75:604.2-605
Background Psoriatic arthritis (PsA) is a common form of chronic arthritis strongly associated with the skin disease psoriasis. The gender distribution is considered equal but it is suggested that their might be gender related differences in disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8518a87d0609ac42eb4f657da552a1b
https://doi.org/10.1136/annrheumdis-2016-eular.5831
https://doi.org/10.1136/annrheumdis-2016-eular.5831
Autor:
Rik Lories, V. Taelman, K. de Vlam, G. De Brabanter, I Peene, Michel Malaise, M. Maertens, A. Nzeusseu Toukap, H. Leroi, S. Dall'Armellina, F. Van den Bosch, M. Van Den Berghe, F. Van Bruwaene, P. Geusens, J. Lenaerts, Serge Steinfeld, J. Qu, Rik Joos
Publikováno v:
Annals of the Rheumatic Diseases. 75:1156.3-1157
Background Psoriatic Arthritis is often considered to be predominantly peripheral presenting with arthritis, dactylitis and enthesitis. Consequently randomized controlled trials, screening procedures for early detection and treatment strategies large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0da00c4ab4574bf1264cbc90d9186827
https://doi.org/10.1136/annrheumdis-2016-eular.5850
https://doi.org/10.1136/annrheumdis-2016-eular.5850
Autor:
S.K. Höweler, G. De Brabanter
Publikováno v:
Reizen en ziekte ISBN: 9789031372225
Avontuurlijke, sportieve reizen zitten in de lift, maar zij vormen een belasting voor niet-getrainde spieren, pezen en gewrichten. Men moet bij de planning dus goed het karakter van de reis bekijken. Worden er speciale eisen aan het bewegingsapparaat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d222dd35412a185cd97253c04d46e091
https://doi.org/10.1007/978-90-313-7223-2_15
https://doi.org/10.1007/978-90-313-7223-2_15
Autor:
M. Van Den Berghe, K. de Vlam, Michel Malaise, F. Van den Bosch, G. De Brabanter, A. Nzeusseu Toukap, J. Qu, V. Taelman, M. Maertens, Rik Lories, Serge Steinfeld, S. Dalli'Armellina, Rik Joos, I Peene, J. Lenaerts, F. Van Bruwaene, H. Leroi, P. Geussens, M. Vanden Berghe
Publikováno v:
Annals of the Rheumatic Diseases. 74:1171.3-1172
Background Psoriatic arthritis is a chronic arthritis with major impact on the physical and psychosocial integrity of the patient. Only few prospective data are available. BEPAS (Belgian Epidemiological Psoriatic Arthritis Study) is a large prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a87a875ddf58692200e9fa3267cf8d0
https://doi.org/10.1136/annrheumdis-2015-eular.5560
https://doi.org/10.1136/annrheumdis-2015-eular.5560
Autor:
Rik Joos, Rene Westhovens, J. Remans, E. Van Essche, K. Van der Elst, D. De Cock, I. Ravilingien, F. Raeman, L. Corluy, Johan Vanhoof, K. Vandevyvere, E. Geens, B. Vander Cruyssen, C. Langenaken, G. De Brabanter, A. Sileghem, P. Geusens, Johan Joly, Sabrina Meyfroidt, V. Taelman, A. Durnez, Patrick Verschueren, J. Lenaerts
Publikováno v:
Annals of the Rheumatic Diseases. 74:236.2-237
Background Early intensive treatment to target is recommended in severe early Rheumatoid Arthritis (eRA). However, data are lacking in patients presenting without markers of poor prognosis. Objectives To compare Methotrexate (MTX) with or without Glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e454f42825cfc53c961acd9b48a8920
https://doi.org/10.1136/annrheumdis-2015-eular.3984
https://doi.org/10.1136/annrheumdis-2015-eular.3984
Autor:
Johan Joly, E. Van Essche, Rene Westhovens, V. Taelman, L. Corluy, Sabrina Meyfroidt, J. Remans, K. Vandevyvere, P. Geusens, G. De Brabanter, K. Van der Elst, I. Ravilingien, C. Langenaken, F. Raeman, D. De Cock, B. Vander Cruyssen, E. Geens, Rik Joos, A. Durnez, Patrick Verschueren, J. Lenaerts, Johan Vanhoof, A. Sileghem
Publikováno v:
Annals of the Rheumatic Diseases. 74:139.2-139
Background To date, intensive DMARD combination therapy with glucocorticoids (GCs) is the most effective treatment approach for the management of early Rheumatoid Arthritis (eRA). The ideal content of the combination and the dose of GCs are however n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65c688a886c6075afdfba8b157aca1d2
https://doi.org/10.1136/annrheumdis-2015-eular.4018
https://doi.org/10.1136/annrheumdis-2015-eular.4018
Autor:
Johan Vanhoof, D. De Cock, F. Raeman, A. Sileghem, Rene Westhovens, G. De Brabanter, Johan Joly, E. Van Essche, J. Remans, Isabelle Ravelingien, V. Taelman, Patrick Verschueren, P. Geusens, J. Lenaerts, B. Vander Cruyssen, A. Durnez, K. Van der Elst, Rik Joos, K. Vandevyvere, Sabrina Meyfroidt, E. Geens, L. Corluy, C. Langenaken
Publikováno v:
Annals of the Rheumatic Diseases. 73:220.1-220
Background Whereas early intensive treatment to target is recommended in severe early Rheumatoid Arthritis (eRA), few data are available in patients presenting without bad prognostic markers. Objectives To evaluate the efficacy and safety of methotre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::001adcb41ec042ac4e1dc6824e227548
https://doi.org/10.1136/annrheumdis-2014-eular.2144
https://doi.org/10.1136/annrheumdis-2014-eular.2144
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.